Results 211 to 220 of about 64,431 (291)

Historical Records of Tumours in New Zealand Marine Fishes

New Zealand Journal of Marine and Freshwater Research, Volume 60, Issue 2, June 2026.
Tumours were first described in New Zealand marine fishes in 1982 but those early records have been difficult to access and subsequently few tumours have been collected and little has been published. This review updates records of identified tumours from teleosts in the New Zealand marine environment and may encourage more work to identify background ...
John Brian Jones
wiley   +1 more source

Characterising PMP22-Proximal Partners in a Schwann Cell Model of Charcot-Marie-Tooth Disease Type1A. [PDF]

Biology (Basel)
Holt I, Emery N, Gates MA, Brown SJ, Shirran SL, Fuller HR.   +5 more
europepmc   +1 more source

Freeze‐Derived Microporous Biomaterials for Tissue Engineering Applications

Smart Medicine, Volume 5, Issue 3, June 2026.
Ice‐templating demonstrates significant potential to revolutionize tissue engineering through freeze‐induced microphase separation for fabricating hierarchical, biomimetic scaffolds. This review comprehensively examines recent advances in mechanisms and applications in tissue engineering, such as 3D cell culture, wound healing, bone regeneration, nerve
Shuangshuang Miao, Xingkui Guo, Chenhui Bai, Wei Zhou, Yiwen Wu, Wanchuan Ding, Jingjing Gan   +6 more
wiley   +1 more source

Electromagnetic exposure changes human Schwann cell motility and transcriptomic profile of hearing-loss-related genes. [PDF]

iScience
Mohamed T, Colciago A, Faroni A, Reid AJ, Ferrero G, Magnaghi V.   +5 more
europepmc   +1 more source

A thermoplastic microfluidic platform with integrated electrospun scaffolds for assessing brain cell‐specific drug selectivity

VIEW, Volume 7, Issue 3, June 2026.
Schematic representation of the microfluidic platform with its advantages. Abstract A major challenge in pharmacology is the limited selectivity of therapeutic compounds toward specific tissues or cells. Drugs often distribute systemically before reaching the intended site of action, affecting nontarget cells and potentially reducing efficacy or ...
Maria Testa, Laura Palumbo, Martina La Rosa, Antonella Girgenti, Fabio Salvatore Palumbo, Pasquale Picone, Francesco Lopresti, Domenico Nuzzo, Vincenzo La Carruba   +8 more
wiley   +1 more source

Etifoxine drives macrophage M2 polarization via Schwann cell-derived progesterone activation of PPARγ to accelerate peripheral nerve repair. [PDF]

Front Cell Neurosci
Guo C, Liu S.
europepmc   +1 more source

Age‐Dependent Remodeling of the Sciatic Nerve Proteome in 5xFAD Mice Can Be Attenuated by Exercise or Donepezil Treatment to Maintain Neuromuscular Function

Aging Cell, Volume 25, Issue 6, June 2026.
Sciatic nerve proteome remodeling, particularly of mitochondrial‐centric pathways, occurs at 4 months of age in 5xFAD mice, coinciding with onset of neuromuscular dysfunction. Exercise or the acetylcholinesterase inhibitor donepezil, begun prior to onset, delays these phenotypes, suggesting early peripheral phenotypes of Alzheimer's Disease may have ...
Matthew H. Brisendine, Dijanira Q. Nieves‐Esparcia, Orion S. Willoughby, Brieann Brown, John R. Brown, Daniel S. Braxton, Shelby N. Henry, Colin S. McCoin, John P. Thyfault, Jill K. Morris, Steven Poelzing, Robert W. Grange, Timothy J. Jarome, Charles P. Najt, Joshua C. Drake   +14 more
wiley   +1 more source

Chemogenetic Schwann cell activation impairs early myelination and triggers adult demyelination in the peripheral nervous system. [PDF]

Front Cell Neurosci
Corral JG, Cheli VT, Santiago-Gonzalez DA, Kedari KG, Paez PM.   +4 more
europepmc   +1 more source

Deferoxamine Improves Radiation‐Induced Peripheral Neuropathy

Journal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT Radiation‐induced peripheral neuropathy (RIPN) is a devastating sequela of radiation therapy (XRT). Current treatment options are limited. Deferoxamine (DFO) has been useful in treating radiation‐induced dermal fibrosis. This study aimed to evaluate DFO for RIPN. Thus, 18 mice received 30Gy of fractionated XRT.
Christopher V. Lavin, Alexander Z. Fazilat, Carter B. Kendig, Palca Shibale, Kelly X. Huang, Sriya Nemani, Jennifer B. Parker, Caleb Valencia, Naga A. R. Ailury, Michelle Griffin, Arash Momeni, Michael T. Longaker, Derrick C. Wan   +12 more
wiley   +1 more source

Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A. [PDF]

Mol Ther Nucleic Acids
Stavrou M, Wallace LM, Thangaraj MP, Taylor NK, Kagiava A, Papacharalambous R, McAllister C, Zender G, Saad NY, Bayazit MB, Heslegrave A, Tryfonos C, Richter J, Zetterberg H, Price B, Salzman R, Kleopa KA, Harper SQ.   +17 more
europepmc   +1 more source